1-3 of 3
Jeffrey Yu
Close
Sort by
Journal Articles

Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post–allogeneic HCT

Clinical Trials & Observations
Mohammad Abu Zaid, Juan Wu, Cindy Wu, Brent R. Logan, Jeffrey Yu, Corey Cutler, Joseph H. Antin, Sophie Paczesny, Sung Won Choi
Journal: Blood
Blood (2017) 129 (2): 162–170.
https://doi.org/10.1182/blood-2016-08-735324
Published: 2017
Includes: Supplemental data
Journal Articles

Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation: Comparison with Viral Infectious Pneumonia

Sachiko Seo, MD PhD, Jeffrey Yu, Isaac C Jenkins, MS, Terry L Stevens-Ayers, MS, Kuypers M Jane, PhD, Huang Meei-Li, PhD, Wendy M Leisenring, PhD, Keith R Jerome, MD PhD, Sophie Paczesny, MD PhD, Michael Boeckh, MD
Journal: Blood
Blood (2015) 126 (23): 1927.
https://doi.org/10.1182/blood.V126.23.1927.1927
Published: 2015
Journal Articles

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation

Christen L Mumaw, BS, Ayman Akil, PhD, Nieves Velez de Mendizabal, PhD, Qing Zhang, Nisha Raiker, BS, Jeffrey Yu, Maribel Diaz-Ricart, PhD, Enric Carreras, MD, Laura S. Haneline, MD, Kent A. Robertson, MD PhD, Lindsey Elmore, Rose Case, Jamie Renbarger, MD, Samir Hanash, MD PhD, Robert R. Bies, PhD, Sophie Paczesny, MD PhD
Journal: Blood
Blood (2014) 124 (21): 663.
https://doi.org/10.1182/blood.V124.21.663.663
Published: 2014